Categories
Bliss GVS Pharma Limited — Board Meeting, 12-05-2026: Outcome of Board Meeting
12-05-2026 · 11:08 pm
The board approved audited financial results for FY26, reporting a consolidated net profit of ₹134.12 Cr and EPS of ₹12.00. A final dividend of ₹1 per share was proposed for shareholder approval. The 41st AGM is set for July 15, 2026.
No comments yet. Be the first to comment!